BIOMAT Database Logo BIOMAT Database Logo

Characterization of a partial deletion of the factor VIII gene in a haemophiliac with inhibitor. 1988

B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Dipartimento di Genetica e Microbiologia, Università di Pavia, Italy.

Genomic DNA from 49 Italian patients affected with severe haemophilia A was analysed by Southern blotting technique using a cDNA probe corresponding to exons 14-26 of coagulation factor VIII. No TaqI site mutation was observed in this sample. A partial deletion, eliminating exons 15-18 and spanning about 13kb, was identified and characterized in one patient with anti-factor VIII antibodies.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D004262 DNA Restriction Enzymes Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1. Restriction Endonucleases,DNA Restriction Enzyme,Restriction Endonuclease,Endonuclease, Restriction,Endonucleases, Restriction,Enzymes, DNA Restriction,Restriction Enzyme, DNA,Restriction Enzymes, DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).

Related Publications

B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder.
October 1977, Lancet (London, England),
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
A deletion involving intron 13 and exon 14 of factor VIII gene in a haemophiliac with anti-factor VIII antibody.
December 1988, Jinrui idengaku zasshi. The Japanese journal of human genetics,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Massive factor-VIII infusion in Haemophiliac with factor-VIII inhibitor, high responder. 1977.
May 2010, Haemophilia : the official journal of the World Federation of Hemophilia,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Development of a factor VIII inhibitor in a newborn haemophiliac.
September 1998, Haemophilia : the official journal of the World Federation of Hemophilia,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
[Treatment of haemorrhages in a haemophiliac with factor-VIII inhibitor (author's transl)].
February 1979, Deutsche medizinische Wochenschrift (1946),
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Spontaneously acquired factor VIII inhibitor in a non-haemophiliac child.
July 1983, Acta paediatrica Scandinavica,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
DDAVP in a non-haemophiliac patient with an acquired factor VIII inhibitor.
July 1985, British journal of haematology,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Successful operation on a haemophiliac with Factor VIII inhibitor treated by plasmapheresis and Factor VIII infusions.
January 1985, Transfusion,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Nonsense mutation in factor VIII gene of a severe haemophiliac patient with anti-factor VIII antibody.
December 1988, Jinrui idengaku zasshi. The Japanese journal of human genetics,
B Bardoni, and M Sampietro, and M Romano, and M Crapanzano, and P M Mannucci, and G Camerino
Characterization of five partial deletions of the factor VIII gene.
June 1987, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!